7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lee AZ et al. Stimulation of cytokines in osteoblasts cultured on enamel matrix derivative. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18585627
da Silva TA et al. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18061491
Andrade FR et al. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18928898
Menezes R et al. Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. 2006 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:16920551
de Lange J et al. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17703964
Giorgetti AP et al. Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20573527
Kaneyama K et al. Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. 2003 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:12973279
Elias LS et al. Markers of bone remodeling in neoplastic and bone-related lesions. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20955951
Qu Z et al. Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. 2011 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:21232997
Ichimiya H et al. Compressive mechanical stress promotes osteoclast formation through RANKL expression on synovial cells. 2007 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:17321443
Kawasaki K et al. Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. 2006 Orthod Craniofac Res pmid:16918678
Fujita S et al. Low-energy laser stimulates tooth movement velocity via expression of RANK and RANKL. 2008 Orthod Craniofac Res pmid:18713151
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Nishijima Y et al. Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. 2006 Orthod Craniofac Res pmid:16764680
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Tan YY et al. Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. 2010 Orthod Craniofac Res pmid:21040465
George A and Evans CA Detection of root resorption using dentin and bone markers. 2009 Orthod Craniofac Res pmid:19627525
Hartsfield JK Pathways in external apical root resorption associated with orthodontia. 2009 Orthod Craniofac Res pmid:19627526
Yamaguchi M RANK/RANKL/OPG during orthodontic tooth movement. 2009 Orthod Craniofac Res pmid:19419454
El Hadj Othmane T et al. [Osteoprotegerin: regulator, protector and marker]. 2008 Orv Hetil pmid:18842549
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Rutges JP et al. Hypertrophic differentiation and calcification during intervertebral disc degeneration. 2010 Osteoarthr. Cartil. pmid:20723612
Sanchez C et al. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. 2009 Osteoarthr. Cartil. pmid:18974013
Bellido M et al. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis. 2011 Osteoarthr. Cartil. pmid:21820069
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Pantsulaia I et al. Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. 2010 Osteoarthr. Cartil. pmid:20633673
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
Jurado S et al. Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. 2010 Osteoporos Int pmid:19436932
Sheng ZF et al. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice. 2009 Osteoporos Int pmid:18496637
Nakashima A et al. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. 2011 Osteoporos Int pmid:20812007
Ulivieri FM et al. Increased osteoprotegerin in Italian haemodialysis patients. 2006 Osteoporos Int pmid:17019516
Findlay DM and Atkins GJ Relationship between serum RANKL and RANKL in bone. 2011 Osteoporos Int pmid:21850548
Atkins GJ et al. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. 2009 Osteoporos Int pmid:18763010
D'Amelio P et al. Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. 2011 Osteoporos Int pmid:21116815
Li YF et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. 2012 Osteoporos Int pmid:21892678
Zhao HY et al. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. 2008 Osteoporos Int pmid:17703270
Campbell GM et al. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. 2011 Osteoporos Int pmid:20480144
Wheater G et al. Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. 2011 Osteoporos Int pmid:21625887
Jørgensen L et al. Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study. 2010 Osteoporos Int pmid:19701599
Ferrari-Lacraz S and Ferrari S Do RANKL inhibitors (denosumab) affect inflammation and immunity? 2011 Osteoporos Int pmid:20571772
Ominsky MS et al. The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. 2007 Osteoporos Int pmid:17384898
Kahl KG et al. Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. 2005 Osteoporos Int pmid:15300363
Mezquita-Raya P et al. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. 2005 Osteoporos Int pmid:15711777
Leder BZ and Finkelstein JS Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. 2005 Osteoporos Int pmid:15856361
Simpson CA et al. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. 2014 Osteoporos Int pmid:24927689
Indridason OS et al. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. 2005 Osteoporos Int pmid:15776220
Fiore CE et al. Hepatitis C-associated osteosclerosis (HCAO): report of a new case with involvement of the OPG/RANKL system. 2005 Osteoporos Int pmid:15983730
Maïmoun L et al. In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. 2011 Osteoporos Int pmid:21359671
Riggs BL et al. Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. 2003 Osteoporos Int pmid:12879223

Table of Content